scholarly journals PCV82 Simulation of Long-Term Clinical Benefits and Costs of Add-On Therapy with Aliskiren in Hypertensive Patients with Diabetic Nephropathy: A German Statutory Health Insurance Perspective

2011 ◽  
Vol 14 (7) ◽  
pp. A379
Author(s):  
J.M. Graf von der Schulenburg ◽  
D. Weycker ◽  
E. Kaiser ◽  
K. Neidhardt ◽  
Y. Brede
2008 ◽  
Vol 17 (3) ◽  
pp. 343-354 ◽  
Author(s):  
Stephanie A.K. Stock ◽  
Björn Stollenwerk ◽  
Marcus Redaelli ◽  
Daniele Civello ◽  
Karl W. Lauterbach

2014 ◽  
Vol 234 (4) ◽  
Author(s):  
Manuel Kallweit ◽  
Anabell Kohlmeier

SummaryExpenditure of the German statutory health insurance scheme will increase significantly in the future. In order to keep the system financially sound, current law plans to levy income independent surcharges. These will be complemented by a tax-financed social compensation scheme. In this paper, we analyse the effects of such surcharges on revenue on Germany’s statutory health insurance using a general equilibrium model with overlapping generations. Afterwards, we further develop the surcharges up to a flat rate employee contribution and ascertain their financial consequences and their employment and growth effects. The allocative effects of such a further development are positive. They will be more considerable if the introduction begins earlier and ends quickly. A moderate expenditure increase and a smaller shape of the compensation scheme will intensify these effects.


2007 ◽  
Vol 14 (3) ◽  
pp. 241-250 ◽  
Author(s):  
Harald Schmidt

AbstractAppeals to personal responsibility for health are controversial in many countries, especially in those that have publicly funded healthcare systems.In Germany, personal responsibility has traditionally been a focal point in the statutory health-insurance scheme. The most recent healthcare reform under the motto 'prevention before treatment, rehabilitation, and long term care' came into force on 1 April 2007 through the Gesetz zur Stärkung des Wettbewerbs in der gesetzlichen Krankenversicherung (GKV-WSG — "Law to strengthen competition among providers of statutory health-insurance scheme"). In significant parts, the law has given further emphasis to the role of personal responsibility. Implications of three important changes are discussed: (1) insured persons may no longer claim free treatment for complications arising from certain 'lifestyle choices'; (2) chronically ill and cancer patients face more stringent compliance requirements or face higher co-payments; and (3) insured persons may cash 'no-claim bonuses' if over at least one year they do not require hospitalisation or prescription medicines.Previous emphasis on personal responsibility has had relatively broad support in Germany. The long-term acceptability of the new measures will depend on several factors, including the structural and financial impact on different providers of statutory health insurance, and the capacities and opportunities of different groups in society to make use of the new provisions.


Sign in / Sign up

Export Citation Format

Share Document